Novugen is proud to announce a new partnership with Malaysia’s oldest and most prestigious public university, University of Malaya (UM), formalised on 29 September 2025 at the Faculty of Pharmacy.
The Novugen Badminton Tournament 2025 made a powerful comeback on 27 September at IOI Sports Centre, Putrajaya, with over 40 teams competing for glory. From intense rallies to loud cheers, the energy was sky-high as colleagues battled it out for the title of Champion!
As we enter the final stretch of 2025, our recent Business Leaders Workshop on September 19 and 20 provided a valuable opportunity for our leadership team to reflect on progress and renew our focus on achieving key organizational goals.
This World Heart Day we’ve asked a few healthcare professionals for their one health tip for a healthier heart and a general health tip.
TikTok: https://t.co/LFCy9NYXF7
Facebook: https://t.co/7U3lXzNnf7?
YouTube: https://t.co/zxkLs5IKCu
Novugen has been granted its fifth patent in Malaysia, this time for Amlodipine and Valsartan (AMVAL), recognizing an innovative manufacturing process. This significant milestone underwent a five-year examination process by MyIPO and was officially granted on 14 August 2025.
As part of Novugen’s continuous efforts to connect academia and industry, we marked another milestone in our growing network of university partnerships with the signing of a Memorandum of Understanding (MoU) with University of Cyberjaya (UoC) on 9 September 2025.
This is your chance to join Malaysia’s first and only USFDA-approved pharmaceutical manufacturing company and become part of our growing team in Production and Quality Operations!
In collaboration with MYFutureJobs, we’re hosting a Walk-In Interview at our Bandar Enstek plant.
We are proud to announce that Novugen has launched Sacubitril and Valsartan Tablets (24mg/26mg, 49mg/51mg, and 97mg/103mg) in the U.S., following the recent Abbreviated New Drug Application (ANDA) approval granted by the U.S. Food and Drug Administration (USFDA).
Selamat Hari Merdeka! 31 August 2025
This Merdeka, Novugen proudly celebrates Malaysia’s journey of independence, resilience, and unity that continues to inspire our pursuit of innovation and excellence in healthcare.
On 20 August 2025, Novugen celebrated the spirit of Merdeka with “Merdeka Breakfast: Makan | Mingle | Moments.” Across all three of our offices, colleagues came together over Malaysia’s beloved nasi lemak, savoury bites, and comforting local drinks.
The countdown begins.
Visit us at Booth #3315 and meet our team, Rahil Mahmood and Victor Borelli, to discover how Novugen is committed to delivering affordable, high-quality medicines to the world.
#Novugen#NACDSTSE2025
We’ve just wrapped up our very first video shoot for Vyta Kita! This exciting milestone featured a podcast with three esteemed cardiologists who lent their voices and insights to the cause.
Novugen successfully concluded its EHS Week 2025 campaign (23–25 July) across both Novugen Bandar Enstek sites, championing the theme “Zero Compromise Towards EHS.”
At Novugen, we believe self-care is a 24/7 commitment, essential not just for personal well-being, but for building a healthier, more resilient workforce. In honour of International Self-Care Day, our HR team curated a full-day wellness experience, themed “Me Time, Anytime”.
Novugen was proud to participate in CPHI South East Asia 2025, where we received overwhelming support at our booth, engaging with regional and global stakeholders eager to explore partnerships and innovation opportunities.
As CPHI South East Asia 2025 begins tomorrow, Novugen looks forward to welcoming delegates from around the world to MITEC Kuala Lumpur.
Drop by Booth Q16 to discover how we are delivering on our mission to strengthen pharmaceutical access and innovation.